Personal information

Activities

Collapse all

Employment (1)

Hospital Universitario Ramón y Cajal: Madrid, Madrid, ES

2018-05-25 to present | Médico Residente (Oncología Médica)
Employment
Source: Self-asserted source
María San Román-Gil

Education and qualifications (1)

Universidad Complutense de Madrid: Madrid, ES

2011-09 to 2017-06 | Medicina (Medicina)
Education
Source: Self-asserted source
María San Román-Gil

Professional activities (2)

Sociedad Española de Oncología Médica: Madrid, ES

2018 to present
Membership
Source: Self-asserted source
María San Román-Gil

European Society for Medical Oncology: Lugano, Ticino, CH

2018 to present
Membership
Source: Self-asserted source
María San Román-Gil

Works (14)

Adoptive T cell therapy for solid tumors: current landscape and future challenges

Frontiers in Immunology
2024 | Journal article
DOI: 10.3389/fimmu.2024.1352805
Part of ISSN: 1664-3224
Contributors: Albarrán, Víctor; San Román, María; Pozas, Javier; Chamorro, Jesús; Rosero, Diana Isabel; Guerrero, Patricia; Calvo, Juan Carlos; González, Carlos; García de Quevedo, Coral; Pérez de Aguado, Patricia et al.
Source: Self-asserted source
María San Román-Gil

Case report: Efficacy of immunotherapy as conversion therapy in dMMR/MSI-H colorectal cancer: a case series and review of the literature

Frontiers in Immunology
2024 | Journal article
DOI: 10.3389/fimmu.2024.1352262
Part of ISSN: 1664-3224
Contributors: San-Román-Gil, María; Martínez-Delfrade, Iñigo; Albarrán-Fernández, Víctor; Guerrero-Serrano, Patricia; Pozas-Pérez, Javier; Chamorro-Pérez, Jesús; Rosero-Rodríguez, Diana; Sotoca-Rubio, Pilar; Barrill-Corpa, Ana Maria; Alia-Navarro, Víctor et al.
Source: Self-asserted source
María San Román-Gil

BRAF Inhibitors in Metastatic Colorectal Cancer and Mechanisms of Resistance: A Review of the Literature

Cancers
2023-10-31 | Journal article
DOI: 10.3390/cancers15215243
Part of ISSN: 2072-6694
Contributors: Patricia Guerrero; Víctor Albarrán; María San Román; Carlos González-Merino; Coral García de Quevedo Suero; Jaime Moreno; Juan Carlos Calvo-Pérez; Guillermo González; Inmaculada Orejana; Jesús Chamorro et al.
Source: Self-asserted source
María San Román-Gil

Current Landscape of Immunotherapy for Advanced Sarcoma

Cancers
2023-04-13 | Journal article
DOI: 10.3390/cancers15082287
Contributors: Víctor Albarrán; María Luisa Villamayor; Javier Pozas; Jesús Chamorro; Diana Isabel Rosero; María San Román; Patricia Guerrero; Patricia Pérez de Aguado; Juan Carlos Calvo; Coral García de Quevedo et al.
Source: check_circle
Crossref

Current Landscape and Potential Challenges of Immune Checkpoint Inhibitors in Microsatellite Stable Metastatic Colorectal Carcinoma

Cancers
2023-01-30 | Journal article
DOI: 10.3390/cancers15030863
Contributors: María San-Román-Gil; Javier Torres-Jiménez; Javier Pozas; Jorge Esteban-Villarrubia; Víctor Albarrán-Fernández; Pablo Álvarez-Ballesteros; Jesús Chamorro-Pérez; Diana Rosero-Rodríguez; Inmaculada Orejana-Martín; Íñigo Martínez-Delfrade et al.
Source: check_circle
Crossref

Receptor Tyrosine Kinase Inhibitors for the Treatment of Recurrent and Unresectable Bone Sarcomas

International Journal of Molecular Sciences
2022-11-09 | Journal article
DOI: 10.3390/ijms232213784
Contributors: Víctor Albarrán; María Luisa Villamayor; Jesús Chamorro; Diana Isabel Rosero; Javier Pozas; María San Román; Juan Carlos Calvo; Patricia Pérez de Aguado; Jaime Moreno; Patricia Guerrero et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Her-2 Targeted Therapy in Advanced Urothelial Cancer: From Monoclonal Antibodies to Antibody-Drug Conjugates

International Journal of Molecular Sciences
2022-10-21 | Journal article
DOI: 10.3390/ijms232012659
Contributors: Víctor Albarrán; Diana Isabel Rosero; Jesús Chamorro; Javier Pozas; María San Román; Ana María Barrill; Víctor Alía; Pilar Sotoca; Patricia Guerrero; Juan Carlos Calvo et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Resistance to RET targeted therapy in Thyroid Cancer: Molecular basis and overcoming strategies

Cancer Treatment Reviews
2022-04 | Journal article
DOI: 10.1016/j.ctrv.2022.102372
Part of ISSN: 0305-7372
Source: Self-asserted source
María San Román-Gil

Molecular Mechanisms of Resistance to Immunotherapy and Antiangiogenic Treatments in Clear Cell Renal Cell Carcinoma

Cancers
2021-11-28 | Journal article
DOI: 10.3390/cancers13235981
Contributors: Pablo Álvarez Ballesteros; Jesús Chamorro; María San Román-Gil; Javier Pozas; Victoria Gómez Dos Santos; Álvaro Ruiz Granados; Enrique Grande; Teresa Alonso-Gordoa; Javier Molina-Cerrillo
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Novel Tyrosine Kinase Targets in Urothelial Carcinoma

International Journal of Molecular Sciences
2021-01-13 | Journal article
DOI: 10.3390/ijms22020747
Contributors: Javier Torres-Jiménez; Víctor Albarrán-Fernández; Javier Pozas; María San Román-Gil; Jorge Esteban-Villarrubia; Alfredo Carrato; Adriana Rosero; Enrique Grande; Teresa Alonso-Gordoa; Javier Molina-Cerrillo
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

Tyrosine Kinase Receptors in Oncology.

International journal of molecular sciences
2020-11-12 | Journal article
DOI: 10.3390/ijms21228529
PMID: 33198314
PMC: PMC7696731
Source: Self-asserted source
María San Román-Gil

Current and Future Role of Tyrosine Kinases Inhibition in Thyroid Cancer: From Biology to Therapy.

International journal of molecular sciences
2020-07-13 | Journal article
DOI: 10.3390/ijms21144951
PMID: 32668761
PMC: PMC7403957
Source: Self-asserted source
María San Román-Gil

BRAF Mutated Colorectal Cancer: New Treatment Approaches.

Cancers
2020-06-14 | Journal article
DOI: 10.3390/cancers12061571
PMID: 32545884
PMC: PMC7353017
Source: Self-asserted source
María San Román-Gil

Targeting Angiogenesis in Pancreatic Neuroendocrine Tumors: Resistance Mechanisms.

International journal of molecular sciences
2019-10-08 | Journal article
DOI: 10.3390/ijms20194949
PMID: 31597249
PMC: PMC6801829
Source: Self-asserted source
María San Román-Gil
How many people are using ORCID?